Hormonal
Continuous Positive Airway Pressure (CPAP) therapy significantly reduces circulating levels of specific pro-inflammatory markers (notably TNFa and adhesion molecules) and improves endothelial function in OSAS patients.
Using CPAP consistently every night is the most effective way to lower the inflammation caused by your sleep apnea. Studies show it significantly reduces harmful markers like TNFa and helps repair your blood vessels. While it takes time to get used to the mask, the protection it offers your heart and brain is substantial.
There is increasing evidence of elevated inflammatory markers in OSAS with a significant fall after effective treatment with continuous positive airway pressure. This evidence is particularly strong for TNFa...
Why this rating
Consistent evidence for TNFa and adhesion molecules; conflicting/unclear evidence for CRP and IL-6.
Source
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
Stephen J. Ryan et al. · Postgraduate Medical Journal · 2009
DOI 10.1136/thx.2008.105577
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →